| Authors: |
Tu X; Department of Radiation Oncology, Mayo Cinic, Rochester, United States of America., Zeng X; Department of Oncology, Mayo Clinic, Rochester, United States of America., Sun Y; Department of Oncology, Mayo Clinic, Rochester, United States of America., Ouyang Y; Department of Oncology, Mayo Clinic, Rochester, United States of America., Zhu L; Department of Oncology, Mayo Clinic, Rochester, United States of America., Yin P; Department of Oncology, Mayo Clinic, Rochester, United States of America., Pavelko KD; Department of Immunology, Mayo Clinic, Rochester, United States of America., Leon-Ferre RA; Department of Medical Oncology, Mayo Clinic, Rochester, United States of America., Jiang Y; Department of Oncology, Mayo Clinic, Rochester, United States of America., Dong H; Departments of Urology and Immunology, Mayo Clinic, Rochester, United States of America., Carter JM; Laboratory Medicine and Pathology Department, University of Alberta, Edmonton, Canada., Zhu S; Department of Oncology, Mayo Cinic, Rochester, United States of America., Sarkaria JN; Department of Radiation Oncology, Mayo Clinic, Rochester, United States of America., Wang L; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, United States of America., Huang J; Department of Oncology, Mayo Cinic, Rochester, United States of America., Luo K; Department of Oncology, Mayo Clinic, Rochester, United States of America., Han Y; Department of Radiation Oncology, Mayo Clinic, Rochester, United States of America., Wu Z; Department of Oncology, Mayo Cinic, Rochester, United States of America., Lou Z; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, United States of America., Mutter RW; Department of Radiation Oncology, Mayo Clinic, Rochester, United States of America. |